Equity income from affiliates reflects the performance of the Company’s joint ventures and other equity method affiliates and was comprised of the following:
|
| | | | | | | | | | | |
Years Ended December 31 | 2013 | | 2012 | | 2011 |
AstraZeneca LP | $ | 352 |
| | $ | 621 |
| | $ | 574 |
|
Other (1) | 52 |
| | 21 |
| | 36 |
|
| $ | 404 |
| | $ | 642 |
| | $ | 610 |
|
(1) Primarily reflects results from Sanofi Pasteur MSD and Johnson & Johnson°Merck Consumer Pharmaceuticals Company (which was disposed of on September 29, 2011).
